50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Our mission is to power precision proteomics to enable the earliest detection of disease.”In use 2026 – now·1 sighting·SEC Form 424B4, filed 2026-04-1789% match
“Our mission is to accelerate proteomics together.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-07-1675% match
“Our mission is to transform the field of proteomics by broadening access to high-quality proteomic data and to help support fundamental advancements across human health and medicine.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2672% match
“Our mission is to unlock the latent power of proteomics in order to facilitate a more complete understanding of human biology and contribute to the relief of suffering and the extension of healthy, meaningful life.”In use 2021 – now·1 sighting·SEC Form S-1/A, filed 2021-10-0871% match
“Our mission is to enhance disease diagnosis by applying cutting-edge genetic diagnostic technologies, enabling earlier and more accurate detection for timely and improved treatment.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3171% match
“Our mission is to detect cancer early, when it can be cured.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1270% match
“The Company’s mission is to revolutionize early detection of a wide array of animal related abnormalities.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-01-1369% match
“Our mission is to enable customers across the continuum of molecular research and clinical testing to unlock valuable insights faster, better and more efficiently - from the raw biological sample to the final interpreted results.”In use 2022 – now·1 sighting·SEC Form 20-F, filed 2022-03-1469% match
“Our mission is to imagine and pioneer new ways to decode the biology of the proteome to improve human health.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0268% match
“Our mission is to enable the promise of genomics to better human health.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2568% match
“Our mission is to boldly innovate to create trusted solutions that detect, predict, and prevent disease.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1968% match
“Our mission is to improve the treatment and detection of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-12-0367% match
“Our mission is to develop and commercialize first-in-class medicines based on novel targets to improve patients’ lives.”In use 2022 – now·1 sighting·SEC Form 20-F, filed 2022-03-2467% match
“Our mission is to profitably accelerate drug discovery.”In use 2005 – now·1 sighting·SEC Form 10-K/A, filed 2005-04-2967% match
“Our mission is to ‘democratize’ genetic analysis research with products that enable customers to detect and analyze complex genetic diseases by ultra-sensitive screening and monitoring of cell-free genomic targets.”In use 2015 – now·1 sighting·SEC Form S-1/A, filed 2015-03-3167% match
“Our mission is to detect cancer and disease at earlier, more treatable stages by making screening easy and accessible.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-08-1867% match
“Our mission is to discover and develop best- and first-in-class medicines for a broad range of difficult-to-treat diseases in collaboration with our partners.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-04-0867% match
“Our mission is to discover and develop novel therapeutics to address significant medical needs.”In use 2007 – now·1 sighting·SEC Form 10-K, filed 2007-03-1966% match
“Our mission is to leverage our unique insights into the chromatin regulatory system to pioneer the discovery, development and commercialization of a new class of therapies that transform the lives of patients suffering from a wide spectrum of diseases with high unmet need.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1166% match
“Our mission is to discover and develop a pipeline of EPBs to treat a broad range of diseases and disorders, with an initial focus on cancers with a high unmet medical need.”In use 2022 – now·1 sighting·SEC Form 20-F, filed 2022-04-2666% match
“Our mission is to develop and manufacture intelligent diagnostic solutions that transform the power of diagnostics into a healthier future for everyone.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-02-2366% match
“Our mission is to advance the understanding of fibrosis by building a biology-, chemistry- and screening- based engine to drive drug development across the spectrum of fibrotic diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-0166% match
“Our mission is to leverage unique insights into protein motion to transform the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of small molecule therapies.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2666% match
“Our mission is to enable patients with these disorders to live fuller and healthier lives through the discovery and development of transformative precision peptide therapies.”In use 2025 – now·1 sighting·SEC Form 424B4, filed 2025-09-2566% match
“Our mission is to accelerate the discovery, development and global access to targeted radioligand therapies.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2766% match
“Our mission is to leverage an integrated and extensive genomics and transcriptomics discovery engine to identify antibodies targeted to newly discovered neoepitopes and to mobilize the human immune system of cancer patients to kill tumor cells and facilitate long-term remission.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-03-1566% match
“Our mission is to develop products and services based on leading genomics technologies that improve outcomes and enable improved effectiveness, productivity and safety in the research efforts of drug discovery and development companies worldwide.”In use 2003 – now·1 sighting·SEC Form 10-K, filed 2003-03-1965% match
“Our mission is to deliver innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-2465% match
“Our mission is to provide life science researchers with highly validated products and services to advance biological research and achieve their goals faster.”In use 2023 – now·1 sighting·SEC Form 20-F, filed 2023-03-2065% match
“Our mission is to improve the delivery of healthcare and optimize patient outcomes by leveraging the latest advancements in precision medicine and software technology to enable true value-based care.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-04-0165% match
“Our mission is to develop first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy, or DMD, and other rare disorders.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-03-2765% match
“Our mission is to research, develop, design and manufacture, and market to primary care physicians and other healthcare professionals, comprehensive, cutting edge early detection and diagnostic technologies that are non-invasive, easy to administer and generate data that is easy to interpret.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-05-2065% match
“Our mission is to bring context to the world of biology and human health through the power of spatial phenotyping.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1765% match
“Our mission is to improve health with technologies that transform the way that antibody-based therapies are discovered.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-02-2565% match
“Our mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-03-0665% match
“Our mission is to enable the rapid development of innovative therapeutics by pushing the frontiers of drug discovery technologies.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0465% match
“Our mission is to develop novel therapies by utilizing our disease-agnostic platform to address areas of high unmet medical need, initially in cancer and neurologic diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-1065% match
“Our mission is to translate complex, powerful biology with rigor and urgency into life-changing medicines.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1165% match
“Our mission is to enable the future of medicine for a new era of life sciences.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-0764% match
“Our mission is to commercialize lifesaving, mobile breath sensor technologies that enable professionals to more efficiently screen for the earliest signs of disease or the presence of drugs, enabling improved health outcomes, traffic safety and significant cost reduction.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-05-0564% match
“Our mission is to enable the practice of P4 medicine: personalized, predictive, preventive and participatory.”In use 2012 – now·1 sighting·SEC Form 10-K, filed 2012-02-2864% match
“Our mission is to empower physicians to positively impact patient care through the delivery of innovative molecular diagnostics services.”In use 2013 – now·1 sighting·SEC Form 10-K, filed 2013-03-2564% match
“Our mission is to provide drug and product developers with superior scientific research, high-quality research models and innovative analytical instrumentation in order to bring revolutionary new drugs and products to market quickly and safely.”In use 2021 – now·1 sighting·SEC Form S-1, filed 2021-12-2364% match
“Our mission is to bring forth the next wave of precision oncology therapies that are more selective, more effective and deeply personalized with the goal of altering the course of disease and improving clinical outcomes for patients with cancer.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1764% match
“Our mission is to combine the ingenuity of people with the power of data and technology to achieve new victories against cancer.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-11-2564% match
“Our mission is to transform cancer treatment and prevention globally by driving technological innovation and accelerating the adoption of precision oncology medicine.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-06-2264% match
“Our mission is to use phage display to discover and develop novel products focused on major unmet medical needs.”In use 2001 – now·1 sighting·SEC Form 10-K, filed 2001-04-0264% match
“Our mission is to advance and grow a portfolio of innovative, early-stage oncology assets based on the latest scientific breakthroughs focused on overcoming immune resistance and expanding the addressable patient population.”In use 2023 – now·1 sighting·SEC Form 20-F, filed 2023-07-3164% match
“Our mission is to become a leading global, fully integrated biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies to address global unmet medical needs primarily in hematological malignancies.”In use 2025 – now·1 sighting·SEC Form 424B4, filed 2025-01-2464% match
“Our mission is to expand access to mass spectrometry (“MS”) and its use through the deployment of devices designed specifically for the appropriate levels of precision required in high-volume, real-time testing environments such as airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, law enforcement centers, and industrial locations.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-09-2064% match
Showing 1–50 of 50